Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05548972 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

G7 Dual Mobility With Vivacit-E or Longevity PMCF

StatusEnrolling by Invitation
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Re-verified, no change to tracked fieldsv8
  2. Study sites: 7 to 10v7
  3. Study sites: 5 to 7v6
  4. Study sites: 4 to 5v5
  5. Phase: Not specified to Not applicable Study sites: 1 to 4v4 Show 1 more changeShow less
    • Study sites: 1 to 4
Show 2 earlier versionsHide 2 earlier versions
  1. Trial status: Not Yet Recruiting to Enrolling by Invitation Study sites: 0 to 1 · Start date changed from estimate of Mar 2023 to Mar 20, 2023v3 Show 2 more changesShow less
    • Study sites: 0 to 1
    • Start date changed from estimate of Mar 2023 to Mar 20, 2023
  2. Start date: Jan 2023 to Mar 2023 Secondary endpoints: 5 to 4v2 Show 1 more changeShow less
    • Secondary endpoints: 5 to 4

    See this version in full on ClinicalTrials.gov ↗

  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study is a global, multi-center, prospective, non-controlled, non-randomized, post-market clinical follow-up study. The main objectives of this study are to confirm the long-term safety, performance, and clinical benefits of the G7 Dual Mobility Acetabular System when used with the Vivacit-E or Longevity polyethylene hip bearing and instrumentation in primary total and revision (total) hip arthroplasty
Trial Details
NCT Number NCT05548972
Lead Sponsor Zimmer Biomet
Conditions Hip Osteoarthritis, Rheumatoid Arthritis, Joint Diseases, Avascular Necrosis, Dislocation, Hip, Femoral Neck Fractures, Trochanteric Fractures, Revision Surgeries
Enrollment 358 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov